{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:37:07Z","timestamp":1792643827307,"version":"4.5.0"},"reference-count":138,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2005,1,26]],"date-time":"2005-01-26T00:00:00Z","timestamp":1106697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,1,26]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>We present a consensus document on the diagnosis and management of C1 inhibitor deficiency, a syndrome characterized clinically by recurrent episodes of angio-oedema. In hereditary angio-oedema, a rare autosomal dominant condition, C1 inhibitor function is reduced due to impaired transcription or production of non-functional protein. The diagnosis is confirmed by the presence of a low serum C4 and absent or greatly reduced C1 inhibitor level or function. The condition can cause fatal laryngeal oedema and features indistinguishable from gastrointestinal tract obstruction. Attacks can be precipitated by trauma, infection and other stimulants. Treatment is graded according to response and the clinical site of swelling. Acute treatment for severe attack is by infusion of C1 inhibitor concentrate and for minor attack attenuated androgens and\/or tranexamic acid. Prophylactic treatment is by attenuated androgens and\/or tranexamic acid. There are a number of new products in trial, including genetically engineered C1 esterase inhibitor, kallikrein inhibitor and bradykinin B2 receptor antagonist. Individual sections provide special advice with respect to diagnosis, management (prophylaxis and emergency care), special situations (childhood, pregnancy, contraception, travel and dental care) and service specification.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2005.02726.x","type":"journal-article","created":{"date-parts":[[2005,2,23]],"date-time":"2005-02-23T13:14:44Z","timestamp":1109164484000},"page":"379-394","source":"Crossref","is-referenced-by-count":341,"title":["C1 inhibitor deficiency: consensus document"],"prefix":"10.1093","volume":"139","author":[{"given":"M M","family":"Gompels","sequence":"first","affiliation":[{"name":"Department of Immunology and Immunogenetics, North Bristol NHS Trust, Southmead Hospital, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R J","family":"Lock","sequence":"additional","affiliation":[{"name":"Department of Immunology and Immunogenetics, North Bristol NHS Trust, Southmead Hospital, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Abinun","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Newcastle General Hospital, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C A","family":"Bethune","sequence":"additional","affiliation":[{"name":"Department of Immunology, Derriford Hospital, Plymouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Davies","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Great Ormond Street Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Grattan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Norfolk and Norwich University Hospital, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A C","family":"Fay","sequence":"additional","affiliation":[{"name":"Department of Immunology, Newcastle General Hospital, Newcastle-upon-Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H J","family":"Longhurst","sequence":"additional","affiliation":[{"name":"Department of Immunology, St Bartholomew's Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Morrison","sequence":"additional","affiliation":[{"name":"Department of Immunology and Immunogenetics, North Bristol NHS Trust, Southmead Hospital, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Price","sequence":"additional","affiliation":[{"name":"Department of Immunology and Immunogenetics, North Bristol NHS Trust, Southmead Hospital, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Price","sequence":"additional","affiliation":[{"name":"Primary Immunodeficiency Association, Alliance House, Caxton Street, London, UK, and"},{"name":"Department of Dermatology, Brighton and Sussex University Hospitals Trust, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Watters","sequence":"additional","affiliation":[{"name":"Department of Immunology and Immunogenetics, North Bristol NHS Trust, Southmead Hospital, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,2,7]]},"reference":[{"key":"2022010900430944300_b1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00000441-198207000-00001","article-title":"Hereditary angioedema: an appraisal of 104 cases","volume":"284","author":"Cicardi","year":"1982","journal-title":"Am J Med Sci"},{"key":"2022010900430944300_b2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jcp.55.4.266","article-title":"Current management of hereditary angio-oedema (C1 esterase inhibitor deficiency)","volume":"55","author":"Fay","year":"2002","journal-title":"J Clin Pathol"},{"key":"2022010900430944300_b3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0171-2985(98)80040-5","article-title":"Molecular genetics of C-inhibitor","volume":"199","author":"Tosi","year":"1998","journal-title":"Immunobiology"},{"key":"2022010900430944300_b4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0171-2985(98)80041-7","article-title":"Pathogenetic and clinical aspects of C1 inhibitor deficiency","volume":"199","author":"Cicardi","year":"1998","journal-title":"Immunobiology"},{"key":"2022010900430944300_b5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0171-2985(98)80042-9","article-title":"Regulation of C1-inhibitor synthesis","volume":"199","author":"Prada","year":"1998","journal-title":"Immunobiology"},{"key":"2022010900430944300_b6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","article-title":"Hereditary angioedema with normal C1-inhibitor activity in women","volume":"356","author":"Bork","year":"2000","journal-title":"Lancet"},{"key":"2022010900430944300_b7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00005792-199207000-00003","article-title":"Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients","volume":"71","author":"Agostoni","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"2022010900430944300_b8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.md.0000085055.63483.09","article-title":"Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies","volume":"82","author":"Cicardi","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"2022010900430944300_b9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1126\/science.173.3996.553","article-title":"C-1 inhibitor: evidence for decreased hepatic synthesis in hereditary angioedema","volume":"173","author":"Johnson","year":"1971","journal-title":"Science"},{"key":"2022010900430944300_b10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1567-5769(02)00162-5","article-title":"Bradykinin and the pathophysiology of angioedema","volume":"3","author":"Cugno","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"2022010900430944300_b11","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1172\/JCI117780","article-title":"Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443\u2192Val substitution and functional analysis of the recombinant mutant protein","volume":"95","author":"Zahedi","year":"1995","journal-title":"J Clin Invest"},{"key":"2022010900430944300_b12","doi-asserted-by":"crossref","first-page":"983","DOI":"10.4049\/jimmunol.159.2.983","article-title":"Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases","volume":"159","author":"Zahedi","year":"1997","journal-title":"J Immunol"},{"key":"2022010900430944300_b13","first-page":"793","article-title":"The C-1 inhibitor deficiency","volume":"30","author":"Carrer","year":"1992","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"2022010900430944300_b14","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0196-0644(88)80450-5","article-title":"Hereditary angioedema","volume":"17","author":"Moore","year":"1988","journal-title":"Ann Emerg Med"},{"key":"2022010900430944300_b15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0002-9343(90)90535-L","article-title":"Hereditary angioedema: its diagnostic and management perspectives","volume":"88","author":"Sim","year":"1990","journal-title":"JAMA"},{"key":"2022010900430944300_b16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0091-6749(74)90119-5","article-title":"Erythema marginatum preceding hereditary angioedema","volume":"53","author":"Starr","year":"1974","journal-title":"J Allergy Clin Immunol"},{"key":"2022010900430944300_b17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2133.1979.tb11884.x","article-title":"Reticulate erythema \u2212 a prodrome in hereditary angio-oedema","volume":"101","author":"Williamson","year":"1979","journal-title":"Br J Dermatol"},{"key":"2022010900430944300_b18","doi-asserted-by":"crossref","first-page":"580","DOI":"10.7326\/0003-4819-84-5-580","article-title":"Hereditary angioedema: the clinical syndrome and its management","volume":"84","author":"Frank","year":"1976","journal-title":"Ann Intern Med"},{"key":"2022010900430944300_b19","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1079-2104(97)90146-3","article-title":"Hereditary angioedema: case report and review of management","volume":"83","author":"Karlis","year":"1997","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2022010900430944300_b20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-9343(02)01526-7","article-title":"Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy","volume":"114","author":"Bork","year":"2003","journal-title":"Am J Med"},{"key":"2022010900430944300_b21","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1471-0528.1988.tb06585.x","article-title":"Hereditary angioneurotic oedema and pregnancy. Case reports and review of the literature","volume":"95","author":"Chappatte","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"2022010900430944300_b22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2214\/ajr.116.2.256","article-title":"Hereditary angioneurotic edema of the gastrointestinal tract","volume":"116","author":"Pearson","year":"1972","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"2022010900430944300_b23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1055\/s-1999-14","article-title":"Hereditary angioedema with gastrointestinal involvement: endoscopic appearance","volume":"31","author":"Hara","year":"1999","journal-title":"Endoscopy"},{"key":"2022010900430944300_b24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jcp.55.2.145","article-title":"A multi-centre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency","volume":"55","author":"Gompels","year":"2002","journal-title":"J Clin Pathol"},{"key":"2022010900430944300_b25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1537-2995.1998.38698326333.x","article-title":"randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema","volume":"38","author":"Kunschak","year":"1998","journal-title":"Transfusion"},{"key":"2022010900430944300_b26","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/clinchem\/34.8.1618","article-title":"Age- and sex-specific pediatric reference intervals: study design and methods illustrated by measurement of serum proteins with the Behring LN Nephelometer","volume":"34","author":"Lockitch","year":"1988","journal-title":"Clin Chem"},{"key":"2022010900430944300_b27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1203\/00006450-199402000-00012","article-title":"C1 inhibitor and diagnosis of hereditary angioedema in newborns","volume":"35","author":"Nielsen","year":"1994","journal-title":"Pediatr Res"},{"key":"2022010900430944300_b28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1046\/j.1365-2133.2003.05231.x","article-title":"Misdiagnosis of hereditary angioedema (Type 1 and Type 2)","volume":"148","author":"Gompels","year":"2003","journal-title":"Br J Dermatol"},{"key":"2022010900430944300_b29","first-page":"129","article-title":"Acquired angioedema associated with sinusitis","volume":"10","author":"Watson","year":"2000","journal-title":"J Invest Allergol Clin Immunol"},{"key":"2022010900430944300_b30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000467853","article-title":"Acquired C1 inhibitor deficiency with angioedema symptoms in a patient infected with Echinococcus granulosus","volume":"2","author":"Cicardi","year":"1985","journal-title":"Complement"},{"key":"2022010900430944300_b31","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0091-6749(99)70249-6","article-title":"Refractory exacerbations of hereditary angioedema with associated Helicobacter pylori infection","volume":"103","author":"Rais","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"2022010900430944300_b32","first-page":"513","article-title":"Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection","volume":"37","author":"Farkas","year":"1999","journal-title":"Z Gastroenterol"},{"key":"2022010900430944300_b33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00405-002-0481-y","article-title":"Angioneurotic edemas of the upper aerodigestive tract after ACE-inhibitor treatment","volume":"259","author":"Tisch","year":"2002","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2022010900430944300_b34","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1081-1206(10)62208-9","article-title":"Hereditary angioedema first apparent in the ninth decade during treatment with ACE inhibitor","volume":"87","author":"Berkun","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2022010900430944300_b35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1081-1206(10)62496-9","article-title":"Unmasking of acquired autoimmune C1-inhibitor deficiency by an angiotensin-converting enzyme inhibitor","volume":"86","author":"Kleiner","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2022010900430944300_b36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00002018-200225020-00001","article-title":"Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema?","volume":"25","author":"Howes","year":"2002","journal-title":"Drug Safety"},{"key":"2022010900430944300_b37","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1592\/phco.22.13.1173.33517","article-title":"Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema","volume":"22","author":"Abdi","year":"2002","journal-title":"Pharmacotherapy"},{"key":"2022010900430944300_b38","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1001\/archinte.164.8.910","article-title":"Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment","volume":"164","author":"Cicardi","year":"2004","journal-title":"Arch Intern Med"},{"key":"2022010900430944300_b39","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJM197208312870907","article-title":"Tranexamic acid therapy in hereditary angioneurotic edema","volume":"287","author":"Sheffer","year":"1972","journal-title":"N Engl J Med"},{"key":"2022010900430944300_b40","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM197204132861503","article-title":"Epsilon aminocaproic acid therapy of hereditary angioneurotic edema: a double blind study","volume":"286","author":"Frank","year":"1972","journal-title":"N Engl J Med"},{"key":"2022010900430944300_b41","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJM197612232952602","article-title":"Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities","volume":"295","author":"Gelfand","year":"1976","journal-title":"N Engl J Med"},{"key":"2022010900430944300_b42","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0002-9343(79)91184-7","article-title":"Prophylaxis of attacks of hereditary angioedema","volume":"66","author":"Rothbach","year":"1979","journal-title":"Am J Med"},{"key":"2022010900430944300_b43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0091-6749(80)90181-5","article-title":"Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema","volume":"65","author":"Agostoni","year":"1980","journal-title":"J Allergy Clin Immunol"},{"key":"2022010900430944300_b44","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0140-6736(78)90883-8","article-title":"Anabolic steroids in hereditary angiooedema","volume":"i","author":"Gould","year":"1978","journal-title":"Lancet"},{"key":"2022010900430944300_b45","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0091-6749(81)90181-0","article-title":"Clinical and biochemical effects of stanozolol therapy for hereditary angioedema","volume":"68","author":"Sheffer","year":"1981","journal-title":"J Allergy Clin Immunol"},{"key":"2022010900430944300_b46","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0091-6749(87)80277-4","article-title":"Hereditary angioedema: a decade of management with stanozolol","volume":"80","author":"Sheffer","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"2022010900430944300_b47","doi-asserted-by":"crossref","first-page":"739","DOI":"10.7326\/0003-4819-53-4-739","article-title":"Methyltestosterone therapy for hereditary episodic edema (hereditary angioneurotic edema)","volume":"53","author":"Spaulding","year":"1960","journal-title":"Ann Intern Med"},{"key":"2022010900430944300_b48","first-page":"391","article-title":"Longterm therapy of hereditary angioedema (HAE). Preventive management with fluoxymesterone and oxymetholone in severely affected males and females","volume":"135","author":"Davis","year":"1974","journal-title":"Johns Hopkins Med J"},{"key":"2022010900430944300_b49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0091-6749(79)90144-1","article-title":"Clinical and biochemical effects of impeded androgen (oxymetholone) therapy of hereditary angioedema","volume":"64","author":"Sheffer","year":"1979","journal-title":"J Allergy Clin Immunol"},{"key":"2022010900430944300_b50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4065\/75.4.349","article-title":"Asphyxiation by laryngeal edema in patients with hereditary angioedema","volume":"75","author":"Bork","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"2022010900430944300_b51","first-page":"1","article-title":"Epsilon\u2013aminocaproic acid (E\u2013ACA) as a therapeutic agent based on 5 year's clinical experience","volume":"448","author":"Nilsson","year":"1966","journal-title":"Acta Med Scand Suppl."},{"key":"2022010900430944300_b52","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1398-9995.1978.tb01537.x","article-title":"Hepatic function and fibrinolysis in patients with hereditary angioedema undergoing long-term treatment with tranexamic acid","volume":"33","author":"Agostoni","year":"1978","journal-title":"Allergy"},{"key":"2022010900430944300_b53","first-page":"1","article-title":"Tranexamic acid therapy is effective treatment in heavy menstrual bleeding","volume":"4","author":"Rybo","year":"1991","journal-title":"Clin Update Safety Ther Adv"},{"key":"2022010900430944300_b54","first-page":"306","article-title":"Clinical problems in the C1-inhibitor deficient patient","volume":"93","author":"Agostoni","year":"1993","journal-title":"Behring Inst Mitt"},{"key":"2022010900430944300_b55","volume-title":"Diagnosis and treatment of hereditary angioedema, a genetically determined deficiency of C1 inhibitor","author":"Abinun","year":"1988"},{"key":"2022010900430944300_b56","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJM197204132861510","article-title":"Therapy of \u2018the neurotic edema\u2019","volume":"286","author":"Donaldson","year":"1972","journal-title":"N Engl J Med"},{"key":"2022010900430944300_b57","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.4065\/71.12.1175","article-title":"Long-term treatment of C1 inhibitor deficiency with epsilon-aminocaproic acid in two patients","volume":"71","author":"Van Dellen","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"2022010900430944300_b58","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/adc.49.8.636","article-title":"Therapy in hereditary angioneurotic oedema","volume":"49","author":"Gwynn","year":"1974","journal-title":"Arch Dis Child"},{"key":"2022010900430944300_b59","first-page":"611","article-title":"Hereditary angioedema","volume":"i","author":"Naish","year":"1979","journal-title":"Lancet"},{"key":"2022010900430944300_b60","article-title":"Antifibrinolytic drugs and haemostatics","volume-title":"British National Formulary","author":"British Medical Association and the Royal Pharmaceutical Society of Great Britain.","year":"2003"},{"key":"2022010900430944300_b61","doi-asserted-by":"crossref","first-page":"809","DOI":"10.7326\/0003-4819-93-6-809","article-title":"Long-term therapy of hereditary angioedema with danazol","volume":"93","author":"Hosea","year":"1980","journal-title":"Ann Intern Med"},{"key":"2022010900430944300_b62","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0091-6749(83)90034-9","article-title":"Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives","volume":"72","author":"Cicardi","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"2022010900430944300_b63","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/archpedi.1967.02090190068004","article-title":"Study of an anabolic steroid: certain effects of oxymetholone on small children","volume":"113","author":"Keele","year":"1967","journal-title":"Am J Dis Child"},{"issue":"Suppl. 3","key":"2022010900430944300_b64","first-page":"15","article-title":"Classification of side effects to danazol therapy","volume":"5","author":"Spooner","year":"1977","journal-title":"J Int Med Res"},{"issue":"Suppl. 3","key":"2022010900430944300_b65","first-page":"109","article-title":"Preliminary experience with danazol in children with precocious puberty","volume":"5","author":"Smith","year":"1977","journal-title":"J Int Med Res"},{"key":"2022010900430944300_b66","first-page":"1032","article-title":"Transient adrenogenital syndrome due to exposure to danazol in utero","volume":"135","author":"Castro-Magana","year":"1981","journal-title":"Am J Dis Child"},{"key":"2022010900430944300_b67","first-page":"474","article-title":"Ambiguous genitalia in a term female infant due to exposure to danazol in utero","volume":"136","author":"Schwartz","year":"1982","journal-title":"Am J Dis Child"},{"issue":"Suppl. 3","key":"2022010900430944300_b68","first-page":"25","article-title":"Metabolic effects of danazol","volume":"5","author":"Wynn","year":"1977","journal-title":"J Int Med Res"},{"key":"2022010900430944300_b69","first-page":"262","article-title":"Liver damage from long-term methyltestosterone","volume":"2","author":"Westaby","year":"1977","journal-title":"Lancet"},{"key":"2022010900430944300_b70","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(72)92649-9","article-title":"Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma","volume":"ii","author":"Johnson","year":"1972","journal-title":"Lancet"},{"key":"2022010900430944300_b71","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(73)90098-6","article-title":"Androgen and hepatocellular carcinoma","volume":"ii","author":"Ziegenfuss","year":"1973","journal-title":"Lancet"},{"key":"2022010900430944300_b72","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(74)90542-X","article-title":"Liver tumours and steroid hormones","volume":"1","author":"Cattan","year":"1974","journal-title":"Lancet"},{"key":"2022010900430944300_b73","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0002-9343(90)90434-F","article-title":"Danazol-induced hepatocellular adenoma","volume":"88","author":"Fermand","year":"1990","journal-title":"Am J Med"},{"key":"2022010900430944300_b74","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(99)00110-5","article-title":"Hepatocelluar adenomas in patients taking danazol for hereditary angio-oedema","volume":"353","author":"Bork","year":"1999","journal-title":"Lancet"},{"key":"2022010900430944300_b75","volume-title":"Oxandrin Fact Sheet","author":"BTG Pharm.","year":"2003"},{"key":"2022010900430944300_b76","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJM199606203342503","article-title":"Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate","volume":"334","author":"Waytes","year":"1996","journal-title":"N Engl J Med"},{"key":"2022010900430944300_b77","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0091-6749(77)90080-X","article-title":"Tranexamic acid: preoperative prophylactic therapy for patients with hereditary angioneurotic edema","volume":"60","author":"Sheffer","year":"1977","journal-title":"J Allergy Clin Immunol"},{"key":"2022010900430944300_b78","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(79)91039-0","article-title":"Hereditary angioedema","volume":"i","author":"Ward Booth","year":"1979","journal-title":"Lancet"},{"key":"2022010900430944300_b79","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archinte.163.10.1229","article-title":"Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency","volume":"163","author":"Bork","year":"2003","journal-title":"Arch Intern Med"},{"issue":"Suppl.","key":"2022010900430944300_b80","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jaci.2004.06.047","article-title":"Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond","volume":"114","author":"Agostoni","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"2022010900430944300_b81","article-title":"Stability of a new formulation of C1-esterase-inhibitor concentrate at room temperature","volume-title":"International Clinical Practice Series","author":"Schulte","year":"2004"},{"key":"2022010900430944300_b82","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0950-3528(88)90014-0","article-title":"Liver tumours","volume":"2","author":"Anthony","year":"1988","journal-title":"Baillieres Clin Gastroenterol"},{"key":"2022010900430944300_b83","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0015-0282(16)53638-3","article-title":"The long-term safety of danazol in women with hereditary angioedema","volume":"54","author":"Zurlo","year":"1990","journal-title":"Fertil Steril"},{"key":"2022010900430944300_b84","first-page":"1054","article-title":"Danazol-induced hepatocellular adenomas. A case report and review of the literature","volume":"115","author":"Kahn","year":"1991","journal-title":"Arch Pathol Lab Med"},{"key":"2022010900430944300_b85","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0168-8278(02)00035-1","article-title":"Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema","volume":"36","author":"Bork","year":"2002","journal-title":"J Hepatol"},{"key":"2022010900430944300_b86","volume-title":"US National Library of Medicine","author":"Anabolic Steroids (systemic).","year":"2004."},{"key":"2022010900430944300_b87","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJM198003063021002","article-title":"Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor","volume":"302","author":"Gadek","year":"1980","journal-title":"N Engl J Med"},{"key":"2022010900430944300_b88","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archinte.161.5.714","article-title":"Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema","volume":"161","author":"Bork","year":"2001","journal-title":"Arch Intern Med"},{"key":"2022010900430944300_b89","first-page":"299","article-title":"Treatment of acute attacks of hereditary angioedema with C1-inhibitor concentrate","volume":"44","author":"Agostoni","year":"1980","journal-title":"Ann Allergy"},{"key":"2022010900430944300_b90","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00001721-199308000-00011","article-title":"Evaluation of solvent\/detergent treated plasma in the management of patients with hereditary and acquired coagulation disorders","volume":"4","author":"Inbal","year":"1993","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2022010900430944300_b91","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0049-3848(02)00044-0","article-title":"Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products","volume":"105","author":"Chandra","year":"2002","journal-title":"Thromb Res"},{"key":"2022010900430944300_b92","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.transci.2003.08.006","article-title":"Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a review","volume":"29","author":"De Serres","year":"2003","journal-title":"Transfus Apheresis Sci"},{"key":"2022010900430944300_b93","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1172\/JCI200214211","article-title":"Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor","volume":"109","author":"Han","year":"2002","journal-title":"J Clin Invest"},{"key":"2022010900430944300_b94","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1006\/prep.2001.1461","article-title":"Expression of C1 esterase inhibitor by the baculovirus expression vector system: preparation, purification, and characterization","volume":"22","author":"Wolff","year":"2001","journal-title":"Protein Expr Purif"},{"key":"2022010900430944300_b95","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1177\/014107688407701213","article-title":"Hereditary angio-oedema: treatment with C1 esterase inhibitor concentrate","volume":"77","author":"Logan","year":"1984","journal-title":"J R Soc Med"},{"key":"2022010900430944300_b96","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00000441-188804000-00004","article-title":"Hereditary angioneurotic oedema","volume":"95","author":"Osler","year":"1888","journal-title":"Am J Med Sci"},{"key":"2022010900430944300_b97","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1365-2796.1996.418764000.x","article-title":"Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikrein\u2013kinin analyses","volume":"239","author":"Nielsen","year":"1996","journal-title":"J Intern Med"},{"key":"2022010900430944300_b98","article-title":"Pregnancy","volume-title":"British National Formulary","author":"British Medical Association and the Royal Pharmaceutical Society of Great Britain.","year":"2003"},{"key":"2022010900430944300_b99","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0038-1649475","article-title":"Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications","volume":"70","author":"Lindoff","year":"1993","journal-title":"Thromb Haemost"},{"key":"2022010900430944300_b100","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1055\/s-2008-1068085","article-title":"Kontrazeption und Schwangerschaft beim heredit\u00e4ren Angio\u00f6dem","volume":"112","author":"B\u00f6ckers","year":"1987","journal-title":"Dtsch Med Wochenschr"},{"key":"2022010900430944300_b101","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2044.1979.tb06276.x","article-title":"Hereditary angioneurotic oedema","volume":"34","author":"Hopkinson","year":"1979","journal-title":"Anaesthesia"},{"key":"2022010900430944300_b102","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1440-0960.1992.tb00050.x","article-title":"Hormonally exacerbated hereditary angioedema","volume":"33","author":"Yip","year":"1992","journal-title":"Australas J Dermatol"},{"key":"2022010900430944300_b103","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000068456","article-title":"Angioedema and oral contraception","volume":"206","author":"Bouittet","year":"2003","journal-title":"Dermatology"},{"key":"2022010900430944300_b104","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0714.1991.tb00908.x","article-title":"Oral manifestations and dental management of patients with hereditary angioedema","volume":"20","author":"Atkinson","year":"1991","journal-title":"J Oral Pathol Med"},{"key":"2022010900430944300_b105","first-page":"1088","article-title":"Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema","volume":"134","author":"Bork","year":"2003","journal-title":"J Am Med Assoc"},{"key":"2022010900430944300_b106","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0278-2391(99)90280-X","article-title":"The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures","volume":"57","author":"Farkas","year":"1999","journal-title":"J Oral Maxillofac Surg"},{"key":"2022010900430944300_b107","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1542\/peds.37.6.1017","article-title":"Hereditary angioneurotic edema: a clinical survey","volume":"37","author":"Donaldson","year":"1966","journal-title":"Pediatrics"},{"key":"2022010900430944300_b108","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-0028-1103919","article-title":"Hereditary angioneurotic edema. Clinical aspects and extended diagnostic and therapeutic possibilities","volume":"104","author":"Bork","year":"1979","journal-title":"Dtsch Med Wochenschr"},{"key":"2022010900430944300_b109","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-4362.1983.tb03351.x","article-title":"Hereditary angioedema","volume":"22","author":"Brickman","year":"1983","journal-title":"Int J Dermatol"},{"key":"2022010900430944300_b110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000463083","article-title":"Inherited C1 inhibitor deficiency","volume":"6","author":"Agostoni","year":"1989","journal-title":"Complement Inflamm"},{"issue":"Suppl. 1","key":"2022010900430944300_b111","first-page":"221","article-title":"Problems of longterm prophylaxis in children with hereditary angioedema","volume":"88","author":"Abinun","year":"1986","journal-title":"Periodicum Biologorum"},{"key":"2022010900430944300_b112","first-page":"1049","article-title":"Hereditary angio-oedema","volume":"64","author":"Bedford","year":"1971","journal-title":"Proc R Soc Med"},{"key":"2022010900430944300_b113","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.0954-6820.1977.tb15724.x","article-title":"Hereditary angioneurotic oedema in Finland. Clinical, immunological and genealogical studies","volume":"201","author":"Ohela","year":"1977","journal-title":"Acta Med Scand"},{"key":"2022010900430944300_b114","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2133.1979.tb05562.x","article-title":"Hereditary angio-oedema: treatment with danazol. Report of a case","volume":"100","author":"Tappeiner","year":"1979","journal-title":"Br J Dermatol"},{"key":"2022010900430944300_b115","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/adc.56.3.229","article-title":"Successful use of danazol for hereditary angio-oedema","volume":"56","author":"Rajagopal","year":"1981","journal-title":"Arch Dis Child"},{"key":"2022010900430944300_b116","first-page":"931","article-title":"Hereditary angioedema: danazol therapy in a 5-year-old child","volume":"147","author":"Barakat","year":"1993","journal-title":"Am J Dis Child"},{"key":"2022010900430944300_b117","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(05)76637-X","article-title":"Danazol therapy for hereditary angio-oedema in children","volume":"354","author":"Farkas","year":"1999","journal-title":"Lancet"},{"key":"2022010900430944300_b118","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1034\/j.1399-3038.2002.01014.x","article-title":"Clinical management of hereditary angio-oedema in children","volume":"13","author":"Farkas","year":"2002","journal-title":"Pediatr Allergy Immunol"},{"key":"2022010900430944300_b119","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0091-6749(97)70095-2","article-title":"Side \u200aeffects \u200aof long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients","volume":"99","author":"Cicardi","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"2022010900430944300_b120","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0140-6736(79)91416-8","article-title":"Danazol and cholesterol metabolism","volume":"1","author":"Fraser","year":"1979","journal-title":"Lancet"},{"key":"2022010900430944300_b121","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1210\/jcem-53-1-149","article-title":"Cholesterol, high density lipoprotein and danazol","volume":"53","author":"Allen","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"2022010900430944300_b122","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/bmj.288.6415.423","article-title":"Hypercholesterolaemia and coronary heart disease: an answer","volume":"288","author":"Oliver","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2022010900430944300_b123","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1365-2133.1969.tb15938.x","article-title":"Hereditary angio-oedema treated with E-aminocaproic acid","volume":"81","author":"Champion","year":"1969","journal-title":"Br J Dermatol"},{"key":"2022010900430944300_b124","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0091-6749(89)90082-1","article-title":"Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency","volume":"83","author":"Bork","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"2022010900430944300_b125","first-page":"144A","article-title":"Hereditary angioedema in children: treatment with C1 inhibitor concentrate","volume-title":"7th International Congress of Immunology, Berlin","author":"Abinun","year":"1989"},{"key":"2022010900430944300_b126","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/S0140-6736(05)76288-7","article-title":"Hereditary angio-oedema in children","volume":"353","author":"Abinun","year":"1999","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"2022010900430944300_b127","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/1043-6618(92)90639-S","article-title":"Replacement therapy in hereditary and acquired angioedema","volume":"6","author":"Agostoni","year":"1992","journal-title":"Pharmacol Res"},{"key":"2022010900430944300_b128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1537-2995.1995.35395184276.x","article-title":"Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate","volume":"35","author":"Cicardi","year":"1995","journal-title":"Transfusion"},{"key":"2022010900430944300_b129","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1537-2995.1996.36196190522.x","article-title":"Hepatitis C and pasteurized C1-inhibitor concentrate","volume":"36","author":"Klarmann","year":"1996","journal-title":"Transfusion"},{"key":"2022010900430944300_b130","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJM199606203342510","article-title":"Hereditary angioedema","volume":"334","author":"Cicardi","year":"1996","journal-title":"N Engl J Med"},{"key":"2022010900430944300_b131","volume-title":"Guidelines on therapeutic products to treat haemophilia and other hereditary coagulation disorders","author":"United Kingdom Haemophilia Centre Directors\u2019 Organisation Executive Committee.","year":"2004"},{"key":"2022010900430944300_b132","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(69)91295-1","article-title":"Replacement therapy in hereditary angioedema. Successful treatment of two patients with fresh frozen plasma","volume":"1","author":"Pickering","year":"1969","journal-title":"Lancet"},{"key":"2022010900430944300_b133","first-page":"317","article-title":"A family study of hereditary angioneurotic oedema","volume":"42","author":"Beck","year":"1973","journal-title":"Q J Med"},{"key":"2022010900430944300_b134","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0091-6749(75)90077-9","article-title":"Hereditary angioedema: the use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery","volume":"55","author":"Jaffe","year":"1975","journal-title":"J Allergy Clin Immunol"},{"key":"2022010900430944300_b135","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1213\/00000539-197707000-00024","article-title":"The anesthetic and perioperative management of a patient with documented hereditary angioneurotic edema","volume":"56","author":"Gibbs","year":"1977","journal-title":"Anaesth Analg"},{"key":"2022010900430944300_b136","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/jama.1994.03520070036029","article-title":"The use of fresh-frozen plasma in hereditary angioedema","volume":"272","author":"Lieberman","year":"1994","journal-title":"JAMA"},{"key":"2022010900430944300_b137","first-page":"541","article-title":"Fresh frozen plasma prophylaxis for hereditary angioedema during pregnancy. A case report","volume":"41","author":"Galan","year":"1996","journal-title":"J Reprod Med"},{"key":"2022010900430944300_b138","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2005.02726.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/139\/3\/379\/42081912\/j.1365-2249.2005.02726.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/139\/3\/379\/42081912\/j.1365-2249.2005.02726.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T08:12:50Z","timestamp":1683015170000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/139\/3\/379\/6440600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,26]]},"references-count":138,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,2,7]]},"published-print":{"date-parts":[[2005,1,26]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2005.02726.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,3]]},"published":{"date-parts":[[2005,1,26]]}}}